Summary
Johnson & Johnson (JNJ) filed an 8-K on April 14, 2015, to announce its first-quarter financial results for the period ended March 29, 2015. The filing includes a press release detailing the company's sales and earnings performance for the quarter. Investors can find specific sales figures, earnings per share, and other key financial metrics within the accompanying press release and supplementary data. This report serves as a crucial update on JNJ's operational and financial health at the start of fiscal year 2015.
Key Highlights
- 1Johnson & Johnson filed an 8-K on April 14, 2015, reporting its Q1 2015 results.
- 2The report's primary purpose is to disclose sales and earnings for the first quarter ended March 29, 2015.
- 3Key financial information is provided through an attached press release (Exhibit 99.15).
- 4Supplementary unaudited comparative sales data and condensed consolidated statements of earnings for Q1 2015 are also included (Exhibit 99.2O).
- 5Investors should refer to the press release and supplementary data for detailed financial performance metrics.
- 6This filing provides an early-year snapshot of JNJ's financial condition and operational results.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce and provide investors with Johnson & Johnson's sales and earnings results for the first quarter of 2015, which ended on March 29, 2015.
Detailed financial results, including sales, earnings, and supplementary data, can be found in the attached press release (Exhibit 99.15) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings for the first quarter (Exhibit 99.2O).
This specific 8-K filing primarily reports historical financial results for the first quarter. While the press release might contain some forward-looking statements as is standard practice, the core of the filing is focused on reporting past performance rather than providing new guidance or outlook.
The financial information reported in this 8-K covers the first quarter of Johnson & Johnson's fiscal year, which ended on March 29, 2015.